SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Meyler's Side Effects of Drugs, 2016,

    CrossRef

  2. 2
    Živilė Gudlevičienė, Alė Smilgevičiūtė-Ivshin, Aurelija Vaitkuvienė, Agnė Šepetienė, Janina Didžiapetrienė, Human papillomavirus and other risk factors in Lithuanian cervical carcinoma patients, Acta medica Lituanica, 2010, 17, 3, 106

    CrossRef

  3. 3
    Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies, The Lancet, 2007, 370, 9599, 1609

    CrossRef

  4. 4
    Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies, International Journal of Cancer, 2007, 120, 4
  5. 5
    Rollyn M Ornstein, Martin M Fisher, Hormonal Contraception in Adolescents, Pediatric Drugs, 2006, 8, 1, 25

    CrossRef

  6. 6
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  7. 7
    A Berrington de González, S Sweetland, J Green, Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis, British Journal of Cancer, 2004,

    CrossRef

  8. 8
    Kate Miller, Paul Blumenthal, Kelly Blanchard, Oral contraceptives and cervical cancer: critique of a recent review, Contraception, 2004, 69, 5, 347

    CrossRef

  9. 9
    Jennifer S Smith, Jane Green, Amy Berrington de Gonzalez, Paul Appleby, Julian Peto, Martyn Plummer, Silvia Franceschi, Valerie Beral, Cervical cancer and use of hormonal contraceptives: a systematic review, The Lancet, 2003, 361, 9364, 1159

    CrossRef

  10. 10
    Néstor Morales-Peza, Prasert Auewarakul, Victoria Juárez, Alejandro Garcı́a-Carrancá, Angel Cid-Arregui, In Vivo Tissue-Specific Regulation of the Human Papillomavirus Type 18 Early Promoter by Estrogen, Progesterone, and Their Antagonists, Virology, 2002, 294, 1, 135

    CrossRef

  11. 11
    Cervical Cytology Practice Guideline of the American Society of Cytopathology, Journal of Lower Genital Tract Disease, 2001, 5, 3
  12. 12
    Ann L. Coker, Laura C. Sanders, Sharon M. Bond, Tsilya Gerasimova, Lucia Pirisi, Hormonal and Barrier Methods of Contraception, Oncogenic Human Papillomaviruses, and Cervical Squamous Intraepithelial Lesion Development, Journal of Women's Health & Gender-Based Medicine, 2001, 10, 5, 441

    CrossRef

  13. 13
    S Andersson, E Rylander, B Larsson, A Strand, C Silfversvärd, E Wilander, The role of human papillomavirus in cervical adenocarcinoma carcinogenesis, European Journal of Cancer, 2001, 37, 2, 246

    CrossRef

  14. 14
    M. Schiff, J. Miller, M. Masuk, L. van Asselt King, K. K Altobelli, C. M Wheeler, T. M Becker, Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women, International Journal of Epidemiology, 2000, 29, 6, 983

    CrossRef

  15. 15
    H. Haverkos, M. Rohrer, W. Pickworth, The cause of invasive cervical cancer could be multifactorial, Biomedicine & Pharmacotherapy, 2000, 54, 1, 54

    CrossRef

  16. 16
    A. Paloma Vizcaino, Victor Moreno, F. Xavier Bosch, Nubia Muñoz, Xoán M. Barros-Dios, D. Maxwell Parkin, International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas, International Journal of Cancer, 1998, 75, 4
  17. 17
    SUSANNE KRÜGER KJÆR, Risk factors for cervical neoplasia in Denmark, APMIS, 1998, 106, S80
  18. 18
    Peter Boyle, Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996, Lung Cancer, 1997, 17, 1, 1

    CrossRef

  19. 19
    Mohammad Ali Khan, Alfredo J. Canhoto, Paul R. Housley, Kim E. Creek, Lucia Pirisi, Glucocorticoids Stimulate Growth of Human Papillomavirus Type 16 (HPV16)-Immortalized Human Keratinocytes and Support HPV16-Mediated Immortalization without Affecting the Levels of HPV16 E6/E7 mRNA, Experimental Cell Research, 1997, 236, 1, 304

    CrossRef

  20. 20
    E.M. Smith, S.R. Johnson, E.J. Figuerres, M. Mendoza, D. Fedderson, T.H. Haugen, L.P. Turek, The Frequency of Human Papillomavirus Detection in Postmenopausal Women on Hormone Replacement Therapy, Gynecologic Oncology, 1997, 65, 3, 441

    CrossRef

  21. 21
    E.M. Stafford, R.S. Stewart, G.R. Teague, R.R. Gomez, B.A. Crothers, T.J. Michel, T.R. Patience, D.C. Moore, Detection of Human Papillomavirus in Cervical Biopsies of Summer Camp ROTC Cadets With Abnormal Papanicolaou Smears, Journal of Pediatric and Adolescent Gynecology, 1996, 9, 3, 119

    CrossRef

  22. 22
    S.E. Namkoong, Clinical application of HPV typing in cervical cancer, International Journal of Gynecology & Obstetrics, 1995, 49, S59

    CrossRef

  23. 23
    David B. Thomas, Roberta M. Ray, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix, Contraception, 1995, 52, 5, 307

    CrossRef

  24. 24
    Christian Kainz, Gerald Gitsch, Harald Heinzl, Gerhard Breitenecker, Incidence of cervical smears indicating dysplasia among Austrian women during the 1980s, BJOG: An International Journal of Obstetrics & Gynaecology, 1995, 102, 7
  25. 25
    David A. Grimes, Katherine E. Economy, Primary prevention of gynecologic cancers, American Journal of Obstetrics and Gynecology, 1995, 172, 1, 227

    CrossRef

  26. 26
    Jan Pontén, Hans-Oiov Adami, Reinhold Bergström, Joakim Dillner, Lars-Gösta Friberg, Leif Gustafsson, Anthony B. Miller, D. Max Parkin, Par Sparén, Dimitrios Trichopoulos, Strategies for global control of cervical cancer, International Journal of Cancer, 1995, 60, 1
  27. 27
    Mark H. Schiffman, Louise A. Brinton, The epidemiology of cervical carcinogenesis, Cancer, 1995, 76, S10
  28. 28
    Rashmi Sinha, Carolin M. Frey, William G. Kammerer, Mary J. McAdams, Edward P. Norkus, Regina G. Ziegler, Importance of supplemental vitamin C in determining serum ascorbic acid in controls from a cervical cancer case-control study: Implications for epidemiological studies, Nutrition and Cancer, 1994, 22, 3, 207

    CrossRef

  29. 29
    D. B. Thomas, Contraceptivos orales y cáncer, Advances in Contraception, 1993, 9, S1, 31

    CrossRef

  30. 30
    Geoffrey Berry, Robert Maclennan, Rodney Shearman, Tatiana Jelihovsky, Joan Cooper Booth, Ramiro Molina, Luis Martinez, Oriana Salas, Alfredo Dabancens, Chen Zhiheng, Tao Yun, Hu Yong Wei, Alvaro Cuadros, Nubia Aristizabal, Baruch Modan, Elaine Ron, Esther Alfandary, J. G. Mati, Patrick Kenya, Alfred Kungu, D. Gatei, Hector Rodriguez Cuevas, Socorro Benavides Salazar, Antonio Palet, Patricia Ontiveros, Pat A. Ibeziako, T. A. Junaid, P. Aghediuno, A. A. Abioye, Ruben A. Apelo, Julietta R. De la Cruz, Jose Baens, Benjamin D. Canlas, Suporn Silpisornkosol, Tieng Pardthaisong, Viruch Charoeniam, Choti Theetranont, Banpot Boosiri, Supawat Chutivongse, Pramuan Virutamasen, Chansuda Wongsrichanalai, Sermsri Sindhavananda, Suporn Koetsawang, Duangdao Rachawat, Amorn Koetsawang, Gustave Riotton, William M. Christopherson, Joseph L. Melnick, Ervin Adam, David B. Thomas, Roberta M. Ray, Elizabeth A. Noonan, Janet L. Stanford, Karin A. Rosenblatt, Susan Holck, Olav Meirik, Timothy M. M. Farley, David B. Thomas, Roberta M. Ray, Invasive squamous-cell cervical carcinoma and combined oral contraceptives: Results from a multinational study, International Journal of Cancer, 1993, 55, 2
  31. 31
    Mustafa Dosemeci, Richard B. Hayes, Renate Vetter, Robert N. Hoover, Margaret Tucker, Kayihan Engin, Mustafa Unsal, Aaron Blair, Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey, Cancer Causes and Control, 1993, 4, 4, 313

    CrossRef

  32. 32
    Andy Stergachis, Epidemiology of the noncontraceptive effects of oral contraceptives, American Journal of Obstetrics and Gynecology, 1992, 167, 4, 1165

    CrossRef

  33. You have free access to this content33
    KAREN F. KELLEY, MIRIAM A. GALBRAITH, STEN H. VERMUND, Genital Human Papillomavirus Infection in Women, Journal of Obstetric, Gynecologic, & Neonatal Nursing, 1992, 21, 6
  34. 34
    Eric C. J. Claas, Willem J. G. Melchers, Hubert G. M. Niesters, Ruud van Muyden, Ernst Stolz, Wim G. V. Quint, Infections of the cervix uteri with human papillomavirus and Chlamydia trachomatis, Journal of Medical Virology, 1992, 37, 1
  35. 35
    G. Gitsch, C. Kainz, M. Studnicka, A. Reinthaller, G. Tatra, G. Breitenecker, Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia, Archives of Gynecology and Obstetrics, 1992, 252, 1, 25

    CrossRef

  36. 36
    G. Breitenecker, G. Gitsch, What's new in diagnosis and treatment of HPV-associated cervical lesions, Pathology - Research and Practice, 1992, 188, 1-2, 242

    CrossRef

  37. 37
    Diana B. Petitti, Deborah Porterfield, Worldwide variations in the lifetime probability of reproductive cancer in women: Implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use, Contraception, 1992, 45, 2, 93

    CrossRef

  38. 38
    P. C. Hannaford, Cervical cancer and methods of contraception, Advances in Contraception, 1991, 7, 4, 317

    CrossRef

  39. 39
    Joseph Monsonego, Henri Magdelenat, François Catalan, Yves Coscas, Laurent Zerat, Xavier Sastre, Estrogen and progesterone receptors in cervical human papillomavirus related lesions, International Journal of Cancer, 1991, 48, 4
  40. 40
    Louise A. Brinton, Oral contraceptives and cervical neoplasia, Contraception, 1991, 43, 6, 581

    CrossRef

  41. 41
    David B. Thomas, The WHO collaborative study of neoplasia and steroid contraceptives: The influence of combined oral contraceptives on risk of neoplasms in developing and developed countries, Contraception, 1991, 43, 6, 695

    CrossRef

  42. 42
    Allan Hildesheim, William C. Reeves, Louise A. Brinton, Carol Lavery, Maria Brenes, Maria Elena De La Guardia, Julio Godoy, William E. Rawls, Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers, International Journal of Cancer, 1990, 45, 5
  43. 43
    J. Cuzick, A. Singer, B.L. De Stavola, J. Chomet, Case-control study of risk factors for cervical intraepithelial neoplasia in young women, European Journal of Cancer and Clinical Oncology, 1990, 26, 6, 684

    CrossRef

  44. 44
    Mark J. Werner, Frank M. Biro, Contraception and sexually transmitted diseases in adolescent females, Adolescent and Pediatric Gynecology, 1990, 3, 3, 127

    CrossRef

  45. 45
    Alan Pater, Mahin Bayatpour, Mary M. Pater, Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives, American Journal of Obstetrics and Gynecology, 1990, 162, 4, 1099

    CrossRef

  46. 46
    Attila T. Lorincz, Mark H. Schiffman, William J. Jaffurs, John Marlow, Allison P. Quinn, Gary F. Temple, Temporal associations of human papillomavirus infection with cervical cytologic abnormalities, American Journal of Obstetrics and Gynecology, 1990, 162, 3, 645

    CrossRef

  47. 47
    James J. Schlesselman, Cancer of the breast and reproductive tract in relation to use of oral contraceptives, Contraception, 1989, 40, 1, 1

    CrossRef

  48. 48
    M. Vessey, D. Grice, Carcinoma of the cervix and oral contraceptives: epidemiological studies, Biomedicine & Pharmacotherapy, 1989, 43, 3, 157

    CrossRef

  49. 49
    Daniel R. Mishell, Contraception, New England Journal of Medicine, 1989, 320, 12, 777

    CrossRef

  50. 50
    Daniel R. Mishell, Correcting misconceptions about oral contraceptives, American Journal of Obstetrics and Gynecology, 1989, 161, 5, 1385

    CrossRef

  51. 51
    Susan S. Devesa, John L. Young, Louise A. Brinton, Joseph F. Fraumeni, Recent trends in cervix uteri cancer, Cancer, 1989, 64, 10
  52. 52
    Zuo-Feng Zhang, D. M. Parkin, Shun-Zhang Yu, J. Estève, Xue-Zhi Yang, Risk factors for cancer of the cervix in a rural chinese population, International Journal of Cancer, 1989, 43, 5
  53. 53
    Susanne K. Kjaer, Chantal Telsen, Birthe J. Haugaard, Elsebeth Lynge, René B. Christensen, Knud A. Møller, Henning Jensen, Paul Poll, Bent F. Vestergaard, Ethel-Michele De Villfers, Ole M. Jensen, Risk factors for cervical cancer in greenland and Denmark: A population-based cross-sectional study, International Journal of Cancer, 1989, 44, 1
  54. 54
    M.P. Vessey, Contraception, 1989,

    CrossRef

  55. 55
    Donna M. Fedorkow, D.Ian Robertson, Maire A. Duggan, Jill G. Nation, S.Elizabeth McGregor, Gavin C.E. Stuart, Invasive squamous cell carcinoma of the cervix in women less than 35 years old: Recurrent versus nonrecurrent disease, American Journal of Obstetrics and Gynecology, 1988, 158, 2, 307

    CrossRef

  56. 56
    Philip A. Corfman, Labeling guidance for combination oral contraceptives, Contraception, 1988, 37, 5, 433

    CrossRef

  57. 57
    D. J. McCance, News on papillomaviruses, Nature, 1988, 335, 6193, 765

    CrossRef

  58. 58
    Valerie Beral, Philip Hannaford, Clifford Kay, ORAL CONTRACEPTIVE USE AND MALIGNANCIES OF THE GENITAL TRACT, The Lancet, 1988, 332, 8624, 1331

    CrossRef

  59. 59
    K.-W. von Eickstedt, M. Lang, 1988,

    CrossRef

  60. 60
    Ross L. Prentice, David B. Thomas, 1987,

    CrossRef

  61. 61
    J. Z. Guo, D. W. Hahn, M. P. Wachter, Hormones, Estrogens and Antiestrogens, Kirk-Othmer Encyclopedia of Chemical Technology,